Reversible Exocrine Pancreatic Insufficiency in the Context of Autonomic Dysfunction: Extending the NOx (Knox) Hypothesis to the Gut-Brain-Pancreas Axis

Abstract

Bruce H Knox

Background: Exocrine pancreatic insufficiency (EPI) is conventionally attributed to irreversible structural disease. Yet pancreatic exocrine output is regulated by a tightly integrated neurohormonal system involving vagal efferents, enteric circuits, gastrointestinal motility, and enteroendocrine signaling [1-4]. Disruption of autonomic regulation may impair exocrine secretion even when the pancreas is structurally intact.

Objective: To extend the NOx (Knox) Hypothesis into pancreatic physiology, proposing that in selected cases EPI may represent a secondary, reversible manifestation of autonomic dysregulation rather than fixed glandular failure.

Methods: Narrative integrative analysis combining longitudinal patient observation with contemporary literature on autonomic regulation, gut–brain–pancreas physiology, and functional gastrointestinal disorders.

Results: Pancreatic insufficiency emerged concurrently with acute autonomic dysfunction and gastropathy, without radiological evidence of pancreatic disease. As autonomic stability improved, the patient demonstrated reduced reliance on pancreatic enzyme replacement therapy (PERT) without deterioration in bowel function, suggesting functional reversibility.

Conclusion: This case supports the hypothesis that secondary, reversible exocrine pancreatic insufficiency can occur in the setting of autonomic dysregulation. The gut–brain–pancreas axis provides a physiological basis for this possibility, while the NOx Hypothesis offers a systems-level framework for explaining multisystem expression and partial functional recovery.

PDF